Abstract
The process by which HIV-infected individuals are tested and identified has changed with the evolving HIV epidemic and public health response. In this review, we discuss the rationale for increased HIV testing as well as the current standards in HIV diagnostics and their inherent limitations. Current policy guidelines for routine HIV testing from the U.S. Preventive Services Task Force and the U.S. Centers for Disease Control and Prevention are divergent. However, national momentum toward the implementation of routine HIV testing programs continues based on the efficacy and feasibility of these programs in terms of HIV case identification and on recent reports of their cost-effectiveness. As routine, voluntary HIV screening programs are established, issues surrounding consent, reporting, and stigma still persist, as does the challenge of effectively linking detected HIV cases to care.
Similar content being viewed by others
References and Recommended Reading
CDC: A glance at the HIV/AIDS epidemic. http://www.cdc.gov/hiv/resources/factsheets/At-A-Glance.htm. Accessed October 11, 2006.
Bozzette SA, Berry SH, Duan N, et al.: The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. N Engl J Med 1998, 339:1897–1904.
Freedberg KA, Samet JH: Think HIV: why physicians should lower their threshold for HIV testing. Arch Intern Med 1999, 159:1994–2000.
Anderson JE, Chandra A, Mosher WD: HIV testing in the United States, 2002. Adv Data 2005:1–32.
Lopez-Quintero C, Shtarkshall R, Neumark YD: Barriers to HIV-testing among Hispanics in the United States: analysis of the National Health Interview Survey, 2000. AIDS Patient Care STDS 2005, 19:672–683.
Wilson SR, Mitchell C, Bradbury DR, Chavez J: Testing for HIV: current practices in the academic ED. Am J Emerg Med 1999, 17:354–356.
Simmons E, Roberts M, Ma M, et al.: Routine testing for HIV in the United States: the intersection between recommendations and practice. AIDS Patient Care STDS 2006, 20:79–83.
Anderson JE, Sansom S: HIV testing among U.S. women during prenatal care: findings from the 2002 national survey of family growth. Matern Child Health J 2006, 10:413–417.
Takahashi TA, Johnson KM, Bradley KA: A population-based study of HIV testing practices and perceptions in 4 U.S. states. J Gen Intern Med 2005, 20:618–622.
Ekwueme DU, Pinkerton SD, Holtgrave DR, Branson BM: Cost comparison of three HIV counseling and testing technologies. Am J Prev Med 2003, 25:112–121.
Kelen GD, Shahan JB, Quinn TC: Emergency department-based HIV screening and counseling: experience with rapid and standard serologic testing. Ann Emerg Med 1999, 33:147–155.
U.S. Food and Drug Administration: Availability of Abbott/Murex Single Use Diagnostic System (SUDS) HIV-1 Test. http://www.fda.gov/Cber/infosheets/abbsuds051001.htm Accessed October 11, 2006.
Branson BM: Home sample collection tests for HIV infection. JAMA 1998, 280:1699–1701.
OraSure receives CLIA waiver for OraQuick Rapid HIV-1 Antibody Test. Business Wire. http://www.bestd.org/STD%20News/2003.01.31_orasure.htm. Accessed October 11, 2006.
Walensky RP, Paltiel AD: Rapid HIV testing at home: does it solve a problem or create one? Ann Intern Med 2006, 145:459–462.
Rapid HIV test distribution—United States, 2003–2005. MMWR Morb Mortal Wkly Rep 2006, 55:673–676.
Branson B, Wesolowski L, Delaney K, et al.: Investigation of reports of excessive false-positive oral fluid rapid HIV tests [abstract 34LBb]. Presented at the 13th Conference on Retroviruses and Opportunistic Infections. Denver, CO; February 5–8, 2006.
Busch MP, Hecht FM: Nucleic acid amplification testing for diagnosis of acute HIV infection: has the time come? AIDS 2005, 19:1317–1319.
Rich JD, Merriman NA, Mylonakis E, et al.: Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: a case series. Ann Intern Med 1999, 130:37–39.
Knipe DM, Howley PM: Fields Virology, 4th edition. Philadelphia: Lippincott Williams and Wilkins; 2001.
CDC: Recommendations for HIV testing services for inpatients and outpatients in acute-care hospital settings. MMWR Recomm Rep 1993, 42:1–6.
Janssen RS, St Louis ME, Satten GA, et al.: HIV infection among patients in U.S. acute care hospitals. Strategies for the counseling and testing of the hospital patients. The Hospital HIV Surveillance Group. N Engl J Med 1992, 327:445–452.
CDC: Revised guidelines for HIV counseling, testing, and referral. MMWR Recomm Rep 2001, 50:1–57.
Advancing HIV prevention: New strategies for a changing epidemic—United States, 2003. MMWR Morb Mortal Wkly Rep 2003, 52:329–332.
Walensky RP, Losina E, Steger-Craven KA, Freedberg KA: Identifying undiagnosed human immunodeficiency virus: the yield of routine, voluntary inpatient testing. Arch Intern Med 2002, 162:887–892.
Routinely recommended HIV testing at an urban urgentcare clinic—Atlanta, Georgia, 2000. MMWR Morb Mortal Wkly Rep 2001, 50:538–541.
Walensky RP, Losina E, Malatesta L, et al.: Effective HIV case identification through routine HIV screening at urgent care centers in Massachusetts. Am J Public Health 2005, 95:71–73.
Lubelchek R, Kroc K, Hota B, et al.: The role of rapid vs conventional human immunodeficiency virus testing for inpatients: effects on quality of care. Arch Intern Med 2005, 165:1956–1960.
Torres GW, Hasnain-Wynia R, Whitmore H, et al.: Hospital HIV testing policies and practices: a national survey. http://www.hret.org/hret/about/content/execsummary.pdf. Accessed October 11, 2006.
Lurie P, Avins AL, Phillips KA, et al.: The cost-effectiveness of voluntary counseling and testing of hospital inpatients for HIV infection. JAMA 1994, 272:1832–1838.
Owens DK, Nease RF Jr, Harris RA: Cost-effectiveness of HIV screening in acute care settings. Arch Intern Med 1996, 156:394–404.
Paltiel AD, Weinstein MC, Kimmel AD, et al.: Expanded screening for HIV in the United States—an analysis of cost-effectiveness. N Engl J Med 2005, 352:586–595.
Sanders GD, Bayoumi AM, Sundaram V, et al.: Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med 2005, 352:570–585.
Salzmann P, Kerlikowske K, Phillips K: Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age. Ann Intern Med 1997, 127:955–965.
Frazier AL, Colditz GA, Fuchs CS, Kuntz KM: Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 2000, 284:1954–1961.
Paltiel AD, Walensky RP, Schackman BR, et al.: Expanded HIV screening in the United States: Effect on clinical outcomes, HIV transmission, and costs. Ann Intern Med, In press.
Walensky RP, Weinstein MC, Kimmel AD, et al.: Routine human immunodeficiency virus testing: an economic evaluation of current guidelines. Am J Med 2005, 118:292–300.
Phillips KA, Fernyak S: The cost-effectiveness of expanded HIV counselling and testing in primary care settings: a first look. AIDS 2000, 14:2159–2169.
Holtgrave DR, Pinkerton SD, Merson M: Estimating the cost of unmet HIV-prevention needs in the United States. Am J Prev Med 2002, 23:7–12.
Frieden TR, Das-Douglas M, Kellerman SE, Henning KJ: Applying public health principles to the HIV epidemic. N Engl J Med 2005, 353:2397–2402.
Bindman AB, Osmond D, Hecht FM, et al.: Multistate evaluation of anonymous HIV testing and access to medical care. Multistate Evaluation of Surveillance of HIV (MESH) Study Group. JAMA 1998, 280:1416–1420.
Grusky O, Roberts KJ, Swanson AN, et al.: Anonymous versus confidential HIV testing: client and provider decision making under uncertainty. AIDS Patient Care STDS 2005, 19:157–166.
Anonymous or confidential HIV counseling and voluntary testing in federally funded testing sites—United States, 1995–1997. MMWR Morb Mortal Wkly Rep 1999, 48:509–513.
Kaiser Family Foundation: HIV Testing in the United States. http://www.kff.org/hivaids/upload/6094-05.pdf. Accessed October 11, 2006.
Jacobs E: Will Bay State switch to names reporting of HIV cases? http://www2.aegis.com/news/bayw/2006/BY060202.html. Accessed October 11, 2006.
Halpern SD: HIV testing without consent in critically ill patients. JAMA 2005, 294:734–737.
HIV testing among pregnant women—United States and Canada, 1998–2001. MMWR Morb Mortal Wkly Rep 2002, 51:1013–1016.
Valdiserri RO, Moore M, Gerber AR, et al.: A study of clients returning for counseling after HIV testing: implications for improving rates of return. Public Health Rep 1993, 108:12–18.
US Department of Health and Human Services. Centers for Disease Control and Prevention: HIV counseling and testing in publicly funded sites: 1995 summary report. http://www.cdc.gov/Hiv/pubs/ct97_doc.pdf. Accessed October 11, 2006.
Bell RA, Truax SR, Ruiz JD, et al.: Predictors of failure to return for HIV test result and counseling by test site type. AIDS Educ Prev 1999, 11:1–13.
Tao G, Branson BM, Kassler WJ, Cohen RA: Rates of receiving HIV test results: data from the U.S. National Health Interview Survey for 1994 and 1995. J Acquir Immune Defic Syndr Hum Retrovirol 1999, 22:395–400.
Samet JH, Freedberg KA, Savetsky JB, et al.: Understanding delay to medical care for HIV infection: the long-term non-presenter. AIDS 2001, 15:77–85.
Walensky RP, Weinstein MC, Smith HE, et al.: Optimal allocation of testing dollars: the example of HIV counseling, testing, and referral. Med Decis Making 2005, 25:321–329.
Screening for HIV: recommendation statement. Ann Intern Med 2005, 143:32–37.
CDC: Revised Recommendations for HIV Testing of Adults, Adolescents and Pregnant Women in Health Care Settings. MMWR Recomm Rep 2006, 55(RR14):1–17.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wolf, L.L., Walensky, R.P. Testing for HIV infection in the United States. Curr Infect Dis Rep 9, 76–82 (2007). https://doi.org/10.1007/s11908-007-0026-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11908-007-0026-z